Stockscreener 앱 받기
44.43
2.59%
-1.18
Agios Pharmaceuticals Inc 주식(AGIO)의 최신 뉴스
Agios Pharmaceuticals CFO sells shares worth $124,634 By Investing.com - Investing.com Australia
Agios Pharmaceuticals CFO sells shares worth $124,634 By Investing.com - Investing.com South Africa
Agios Pharmaceuticals CFO sells shares worth $124,634 - Investing.com
D. E. Shaw & Co. Inc. Buys 316,100 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat
Pfizer Tanked A $5.4 Billion Takeover. Why Crispr, Agios, Beam Could Benefit. - MSN
Agios Pharmaceuticals (NASDAQ:AGIO) Downgraded by Leerink Partnrs - MarketBeat
Where are the Opportunities in (AGIO) - Stock Traders Daily
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Sold by Axa S.A. - MarketBeat
Wall Street SWOT: Agios stock navigates turbulent waters in genetic disease market - Investing.com India
Wall Street SWOT: Agios stock navigates turbulent waters in genetic disease market - Investing.com Canada
Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down to $48.05 - MarketBeat
Agios cut at Leerink on overhang from Pfizer’s Oxbryta withdrawal - MSN
Wall Street SWOT: Agios stock navigates turbulent waters in genetic disease market - Investing.com UK
Do Options Traders Know Something About Agios (AGIO) Stock We Don't? - Yahoo Finance
Agios cut at Leerink on overhang from Pfizer’s Oxbryta withdrawal - Seeking Alpha
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Given Average Rating of "Moderate Buy" by Analysts - MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) Lowered to Market Perform at Leerink Partners - MarketBeat
Pfizer Pulls Key Sickle Cell Drug Over Safety Concerns - Finimize
Agios stock hits 52-week high at $51.25 amid robust growth - Investing.com Canada
Piper Sandler maintains Overweight rating on Agios Pharma stock By Investing.com - Investing.com Canada
Agios stock hits 52-week high at $51.25 amid robust growth - Investing.com
Agios Pharmaceuticals (NASDAQ:AGIO) Sets New 1-Year High at $53.50 - MarketBeat
We're Not Very Worried About Agios Pharmaceuticals' (NASDAQ:AGIO) Cash Burn Rate - Simply Wall St
American Century Companies Inc. Increases Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat
Beta Thalassemia Pipeline 2024: Clinical Trials Assessment, - openPR
Biliary Tract Cancer Pipeline Analysis 2024: FDA Approvals - openPR
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Sold by Profund Advisors LLC - MarketBeat
Farallon Capital Management LLC Acquires 63,900 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat
Stocks of Agios Pharmaceuticals Inc (AGIO) are poised to climb above their peers - SETE News
Acadian Asset Management LLC Makes New Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - Defense World
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Shares Sold by State of New Jersey Common Pension Fund D - MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) Earns Overweight Rating from Cantor Fitzgerald - MarketBeat
Edgestream Partners L.P. Purchases Shares of 42,076 Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat
Seven Eight Capital LP Acquires New Stake in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat
Seven Eight Capital LP Makes New Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - Defense World
Agilon Health Inc [AGL] CEO & President makes an insider purchase of 20,000 shares worth 67188.0. - Knox Daily
Agios Pharmaceuticals (NASDAQ:AGIO) Rating Reiterated by Royal Bank of Canada - MarketBeat
Agios Pharmaceuticals (NASDAQ:AGIO) Rating Reiterated by Royal Bank of Canada - Defense World
Victory Capital Management Inc. Has $2 Million Stake in Agilysys, Inc. (NASDAQ:AGYS) - Defense World
Bike fashion brand AGU saved from collapse - Ruetir
If EPS Growth Is Important To You, Agilysys (NASDAQ:AGYS) Presents An Opportunity - Simply Wall St
Trading Day Triumph: Agilon Health Inc (AGL) Ends at 3.28, a -7.08 Surge/Plunge - The Dwinnex
Agios Pharmaceuticals (AGIO) Appreciated after Positive Testing Results - Yahoo Finance
Agilon Health Inc (AGL) Stock: A Year of Highs and Lows in the Market - The InvestChronicle
Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) Short Interest Down 16.2% in August - MarketBeat
Breaking down AGL’s current quarter earnings estimates - US Post News
Arizona State Retirement System Cuts Position in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - Defense World
Companies Like Agios Pharmaceuticals (NASDAQ:AGIO) Are In A Position To Invest In Growth - Yahoo Finance
FDA Grants Orphan Drug Tag to AGIO's Tebapivat for Rare Cancer - MSN
Headlands Technologies LLC Makes New Investment in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat
Balance Sheet Dive: Agilon Health Inc (AGL)’s Debt-to-Equity and Long-Term Debt/Eq Ratios - The Dwinnex
Drug developers index falls as cancer trials hit setbacks - BioWorld Online
FDA Grants Orphan Drug Tag to AGIO's Tebapivat for Rare Cancer - Yahoo Finance
FDA Grants Orphan Drug Tag to AGIO's Tebapivat for Rare Cancer - Zacks Investment Research
Agios Pharmaceuticals’ tebapivat gains FDA orphan drug designation - Yahoo Finance
Agios Pharmaceuticals’ tebapivat gains FDA orphan drug designation - Pharmaceutical Technology
Agios Pharmaceuticals (NASDAQ:AGIO) Shares Gap Down to $44.52 - MarketBeat
Agios gains FDA orphan drug status for MDS treatment By Investing.com - Investing.com Canada
Q1 2025 EPS Estimates for Agios Pharmaceuticals, Inc. Lowered by Analyst (NASDAQ:AGIO) - MarketBeat
Agios gains FDA orphan drug status for MDS treatment - Investing.com
Agios gains FDA orphan drug status for MDS treatment By Investing.com - Investing.com Australia
Sickle Cell Disease Treatment Market 2024 Consumer Needs – Agios Pharmaceuticals, Bristol-Myers Squibb, CRISPR Therapeutics, Editas Medicine – Cauverynews - Cauverynews
TD Asset Management Inc Acquires 54,054 Shares of Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat
Agios Gets FDA Orphan Designation for Tebapivat in Myelodysplastic Syndromes - MarketWatch
Agios gains FDA orphan drug status for MDS treatment By Investing.com - Investing.com UK
Agios Announces FDA Orphan Drug Designation Granted to Tebapivat (AG-946) for Treatment of Myelodysplastic Syndromes (MDS) - StockTitan
Bank of New York Mellon Corp Has $9.62 Million Holdings in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat
Candriam S.C.A. Invests $13.92 Million in Agios Pharmaceuticals, Inc. (NASDAQ:AGIO) - MarketBeat
0.05%
4.86%
자본화:
|
볼륨(24시간):